跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用唑来膦酸浓溶液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Zoledronic Acid Concentrated Solution for Injection
Approved
化学药品
Zoledronic Acid Concentrated Solution for Injection
Future Health Pharma GmbH
🇨🇳 National Medical Products Administration
Approval Date
Oct 10, 2023
Approval ID
8VgmfesCVyY
Company
Future Health Pharma GmbH
Type
化学药品
Approval Details
Approval Id
8VgmfesCVyY
Approval Number
国药准字HJ20150049
Generic Name
注射用唑来膦酸浓溶液
Generic Name En
Zoledronic Acid Concentrated Solution for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
5ml:4mg
Reg Date
2023-10-10
Expired Date
2028-10-09
Company Name
Future Health Pharma GmbH
Production Company Name
Fresenius Kabi Austria Gmbh
Company Detail Path
/organization/future-health-pharma-gmbh
Production Company Detail Path
/organization/fresenius-kabi-austria-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 10, 2023
Approval ID
8VgmfesCVyY
Type
化学药品
Back to NMPA Approvals
